Industry News
-
2026 Tang Prize Honors Three Pioneers of CAR-T and Adoptive Cell Therapy
Sep 21 2026 -
Beacon Therapeutics’ Laru-zova Becomes the First XLRP Gene Therapy to Meet a Pivotal Endpoint
Sep 21 2026 -
FDA Approves Ultragenyx’s Fayuvi, the First Gene Therapy for Sanfilippo Syndrome Type A
Sep 17 2026 -
Eli Lilly and QurCan Sign a Non-Viral Genetic Medicine Deal for Nervous System Diseases
Sep 16 2026 -
Skyhawk Reports Positive 15-Month Phase 1/2 Data for Oral Huntington’s Candidate SKY-0515
Sep 15 2026 -
HDT Bio Wins ARPA-H GIVE Award to Build Point-of-Care Manufacturing for Personalized RNA Medicines
Sep 15 2026 -
Ractigen to Present First-in-Human RNA Activation Data in Duchenne at the World Muscle Society Congress
Sep 15 2026 -
Nanoscope to Present 4-Year Data for Its AAV Optogenetic Therapy MCO-010 in Retinitis Pigmentosa
Sep 15 2026 -
Cellectis Exits CAR-T and Reinvents Itself as an In Vivo Gene Editing Company
Sep 14 2026